About Us
We firmly believe that regenerative medicine is a crucial key to promoting sustainable human health.
We continuously invest in biotechnology innovation and research, committed to providing safer, more effective, and sustainable treatment options for cancer and other serious illnesses.
On the path to sustainable development, Mr. Tsai Chang-hai, the founder of Chang Sheng, is uniquely dedicated to medical education through a comprehensive approach encompassing "schools - educational resources," "hospitals - holistic healthcare," and "spin-off companies - the practical application of regenerative medicine." This approach enriches medical knowledge, refines medical technology and services, and realizes, embodies, and innovates in the field of regenerative medicine.
-
Home
-
About Us
-
Founder and Company Mission
Let the world see Taiwan through Ever Supreme Bio Technology
Joining hands to usher in a new era of precision and personalized medicine,
embodying the spirit of "Hope for Life, Wish for Health".
Mr. Chang Hai Tsai founded Chang Sheng International Biotechnology Co., Ltd. in 2016, driven by his passion for life sciences and his mission to improve human health.
With a deep understanding of the future potential of regenerative medicine, he resolutely dedicated himself to biotechnology innovation, striving to bring groundbreaking treatment options to patients with cancer and other serious illnesses.
Continuous innovation
and pursuit of excellenc.
Ever Supreme Bio Technology
Committed to leading global cell therapy research and development, aiming to improve human health and enhance the quality of life.
Leading cell therapy research and development
Ever Supreme Bio Technology boasts numerous innovative and groundbreaking patents and technologies, and brings together a team of professional PhD and Master's degree holders from home and abroad, along with a group of consultants with medical backgrounds. It is dedicated to the research and development of new stem cell and cancer immune cell drugs, challenging current medical bottlenecks and providing innovative, effective, and precise personalized medical services.
00 Area
Cell preparation factory area
00 Type
Technology Platform
